$115.67
+6.59 (+6.04%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+143.67%
1Y
+351.13%
YTD
+257.12%
Open$110.89
Previous Close$109.08
Day High$118.32
Day Low$109.26
52W High$115.56
52W Low$23.30
Volume—
Avg Volume1.77M
Market Cap7.30B
P/E Ratio—
EPS$-2.22
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$39.72
Above
SMA 200
$33.17
Above
RSI (14)
70
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
-38.1% upside
Current
$115.67
$115.67
Target
$71.60
$71.60
$49.68
$71.60 avg
$88.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 397.49M | 323.82M | 1.46B |
| Net Income | -81,987,300 | -60,112,887 | -327,760,773 |
| Profit Margin | -20.6% | -19.6% | -22.5% |
| EBITDA | -66,034,277 | -51,105,957 | -326,178,396 |
| Free Cash Flow | — | — | -164,017,098 |
| Rev Growth | +22.8% | +22.8% | +7.9% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |